Coronado Global Resources Quote - CRN | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Australia
ASX
Coronado Global Resources Inc (CRN) Share Price

Coronado Global Resources Inc (CRN)

1.035

0.01

( 0.98% )

Updated: 10:56:48

Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

1.035

Bid

1.03

Offer

1.035

Volume

152,829

1.0325 Day's Range 1.05

0.86 52 Week Range 1.81

Market Cap

Previous Close

1.025

Open

1.04

Last Trade

Last Trade Time

10:56:48

Financial Volume

-

VWAP

-

Average Volume (3m)

2,548,095

Shares Outstanding

1,845,098,247

Dividend Yield

-

PE Ratio

12.29

Earnings Per Share (EPS)

0.08

Revenue

2.89B

Net Profit

156.07M

Sector

Bitmns Coal,lignite Surf Mng

Industry

Bitmns Coal,lignite Surf Mng

Website

www.coronadoglobal.com.au

Headquarters

Wilmington, Delaware, USA

Founded

-

Coronado Global Resources Inc is listed in the Bitmns Coal,lignite Surf Mng sector of the Australian Stock Exchange with ticker CRN. The last closing price for Coronado Global Resources was AUD1.03. Over the last year, Coronado Global Resources shares have traded in a share price range of AUD 0.86 to AUD 1.81.

Coronado Global Resources currently has 1,845,098,247 shares in issue. The market capitalisation of Coronado Global Resources is AUD1.89 billion. Coronado Global Resources has a price to earnings ratio (PE ratio) of 12.29.

Merger Update

RNS Number:3376U Office of Fair Trading 16 January 2004 The OFT has published the text of its decision on the anticipated acquisition by Shin-Etsu Chemical Company of Clariant's Cellulose...

Merger Update

RNS Number:3376U Office of Fair Trading 16 January 2004 The OFT has published the text of its decision on the anticipated acquisition by Shin-Etsu Chemical Company of Clariant's Cellulose...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.035	3.5	1	1.05	1	931090	1.01174171	DE
4	-0.08	-7.17488789238	1.115	1.2	0.98	1473981	1.07601585	DE
12	-0.255	-19.7674418605	1.29	1.35	0.86	2548095	1.07175754	DE
26	-0.165	-13.75	1.2	1.45	0.86	2904765	1.17827568	DE
52	-0.645	-38.3928571429	1.68	1.81	0.86	2487839	1.28487764	DE
156	-0.245	-19.140625	1.28	2.49	0.86	3442138	1.65340521	DE
260	-1.335	-56.3291139241	2.37	2.49	0.4975	3069037	1.44998902	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MHCManhattan Corporation Limited	AUD 0.002 (100.00%)	63.83k
NHEONoble Helium Ltd	AUD 0.004 (100.00%)	250k
PABPatrys Limited	AUD 0.0045 (50.00%)	16.41M
VPRVolt Group Ltd	AUD 0.0015 (50.00%)	2.92M
EQNEquinox Resources Limited	AUD 0.185 (48.00%)	4.09M
NCCONAOS Emerging Opportunities Company Limited	AUD 0.005 (-37.50%)	20k
PLCPremier1 Lithium Ltd	AUD 0.007 (-36.36%)	3.02M
LNRLanthanein Resources Ltd	AUD 0.002 (-33.33%)	149.07k
SANSagalio Energy Ltd	AUD 0.005 (-28.57%)	60k
AMDArrow Minerals Limited	AUD 0.0015 (-25.00%)	5.03M
OVTOvanti Ltd	AUD 0.028 (12.00%)	34.7M
PNRPantoro Limited	AUD 0.105 (0.00%)	21.22M
GTIGratifii Limited	AUD 0.005 (-9.09%)	20.28M
TMXTerrain Minerals Limited	AUD 0.004 (14.29%)	20.19M
TMKTMK Energy Ltd	AUD 0.002 (0.00%)	18.95M

bigsur25

bigsur25 3 minutes ago

60 Days , sixty days to get a solid position , it appears MONI has a long fuse quick flippers will get board and complain .

Bubae

Bubae 3 minutes ago

Looking at the daily volume Continuation Capital probably hasn't even worked through their first 60,200,000 share tranche for fees and expenses yet. Looks like there are buyers in volume for those shares at $0.0015. I would say that there will be all you could ever want available at that price.

Jab44

Jab44 5 minutes ago

So predictable. The 280MM yearly sales projection was never going to be achieved, thus Foley was running out of time.
Now the $6.66 will go down.
I expect to see this case study in a Harvard Business Review someday.

DewDiligence

DewDiligence 6 minutes ago

RVNC 3Q24 results (FWIW):

https://investors.revance.com/investors/Press-Releases/news-details/2024/Revance-Reports-Third-Quarter-2024-Financial-Results-Provides-Corporate-Update/default.aspx

• 3Q24 product sales (Daxxify + dermal fillers) were $58.8M, -10% QoQ and +9%

MiamiGent

MiamiGent 8 minutes ago

Solid link. A refuge in our hectic day.

mascale

mascale 8 minutes ago

Balfour Project drilling, 2022 report, is public information. The Extract at Hiru shows a Comparable transactions analysis--for the shareholder report it is likely for. Other matters appear to be public information for some length of time. It is likely that legal counsel--one or more--is involved

Chrism0000

Chrism0000 9 minutes ago

It's about getting favors from the FDA who is run by the government money talks bull sh walks

Zorax

Zorax 9 minutes ago

Is this your proof that the company is scamming us We don't need no proof. The company will supply that for us.
Cause all the 🤥🤡🤡🤡 in the company itself.

BadaBingPebble

BadaBingPebble 10 minutes ago

Holding them accountable for their own statements isn't negative. It's called accountability. I can't imagine a scenario where any investor wouldn't want that; except for you of course. Keep on begging for your 2's though....

BottomBounce

BottomBounce 10 minutes ago

Silver eyes $50 in 2025 as industrial demand grows and gold-silver ratio narrows
$GLD $GDX $GDXJ $NUGT $BAR $PSLV

BottomBounce

BottomBounce 11 minutes ago

Silver eyes $50 in 2025 as industrial demand grows and gold-silver ratio narrows
$GLD $GDX $GDXJ $NUGT $BAR $SLV

DR_rugby

DR_rugby 11 minutes ago

The thump is getting louder

https://lindemannlaw.ch/insights/litigation-against-credit-suisse-ubs-current-status-and-legal-developments/

Sooner or later they will have to pay out these contracts, termination and close the settlements thoughout the system

Idiot Mayor

Idiot Mayor 11 minutes ago

Well, so much for that theory. Looks like another three months of short attacks.

Gmenfan

Gmenfan 12 minutes ago

DewDiligence

DewDiligence 12 minutes ago

In the same section of RVNC’s 10-Q, it says that the Crown acquisition might not go through, which I consider the best-case scenario despite the uncertainty of such an outcome.

alwayswatching1

alwayswatching1 12 minutes ago

JustGoDeep

JustGoDeep 13 minutes ago

Honorable Mention, Post-Of-The-Day #2, Must Read.

CrashOverride

CrashOverride 13 minutes ago

UK was the right startup environment whilst the FDA will certainly love a nontoxic cure for cancer developed by non BP entity.

BadaBingPebble

BadaBingPebble 13 minutes ago

I'm happy to take that wager anytime any day. And, I'd be willing wager I'm sitting on substantially more shares than you.

Whalatane

Whalatane 14 minutes ago

Mr Mister To the best of my knowledge , generic Renvela is the serum pho drug most prescribed to dialysis patient .
It cost about $1 per capsule and most patients need 2-3 with each meal ...so $6- $9 a day ...... max of $270 a month
Most patients don't like Renvela ( it does work

Longstrongsilver

Longstrongsilver 14 minutes ago

No idea. You’d have to ask the IR guy. You might have better luck than me as apparently he doesn’t even read what I write before replying and telling me to shut up lol. Also don’t tie your carriage to tight to my horse . My query was sincere. I’m not sure if yours are too or you are just a basher.

JustGoDeep

JustGoDeep 14 minutes ago

Honorable Mention, Post-Of-The-Day #1, Must Read.

northam43

northam43 14 minutes ago

Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/7/uhqig2_Completed_Cycles.PNG

meidiot

meidiot 14 minutes ago

I will keep my 10 shares and keep an eye on an UNHINGED CEO.

Coronado Global Resources

Free Battery Metal

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions